Literature DB >> 26012351

The role of the NLRP3 inflammasome in pulmonary diseases.

Nima Hosseinian1, Young Cho1, Richard F Lockey1, Narasaiah Kolliputi2.   

Abstract

Respiratory diseases and lung injuries are one of the leading causes of death in the world. One critical component of these diseases is exaggerated inflammatory response. The recently discovered inflammasome is believed to play a key role in inflammation. The inflammasome is an oligomer of intracellular proteins that, once activated by an insult or damage signal, produces mature cytokines from the interleukin-1 family that mediate an inflammatory response. Previous research has provided evidence that suggests the role of the inflammasome in the pathogenesis of many chronic respiratory diseases and acute lung injuries, such as transfusion-related acute lung injury, ventilator-induced lung injury, asthma, chronic obstructive pulmonary disease and pulmonary fibrosis. This article summarizes recent research on the inflammasome and reviews proposed molecular models of the role of the inflammasome in several prominent lung diseases and injuries.
© The Author(s), 2015.

Entities:  

Keywords:  NLRP3; acute lung injury; chronic respiratory disease; inflammasome; inflammation; interleukin 1; lung

Mesh:

Substances:

Year:  2015        PMID: 26012351     DOI: 10.1177/1753465815586335

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  49 in total

1.  Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma.

Authors:  Sara C Sebag; Olha M Koval; John D Paschke; Christopher J Winters; Omar A Jaffer; Ryszard Dworski; Fayyaz S Sutterwala; Mark E Anderson; Isabella M Grumbach
Journal:  JCI Insight       Date:  2017-02-09

2.  NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Huaying Wang; Chun'er Lv; Shi Wang; Huajuan Ying; Yuesong Weng; Wanjun Yu
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 3.  Mitochondrial Dysfunction in Airway Disease.

Authors:  Y S Prakash; Christina M Pabelick; Gary C Sieck
Journal:  Chest       Date:  2017-03-21       Impact factor: 9.410

4.  Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.

Authors:  Krishna M Boini; Tahir Hussain; Pin-Lan Li; Sai Koka
Journal:  Cell Physiol Biochem       Date:  2017-11-06

5.  NLRP3 inflammasome is essential for the development of chronic obstructive pulmonary disease.

Authors:  Wenlin Yang; Hongyan Ni; Haifeng Wang; Huiling Gu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Fungal β-Glucan Activates the NLRP3 Inflammasome in Human Bronchial Epithelial Cells Through ROS Production.

Authors:  Yanhua Huang; Meng Hua; Xuefan Cui
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

7.  Role of NLRP3 Inflammasome in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Hai Lin; Zhipeng Li; Dong Lin; Chunquan Zheng; Weitian Zhang
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

8.  Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants.

Authors:  Debra L Laskin; Rama Malaviya; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

9.  Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC).

Authors:  Maja Šutić; Antje Motzek; Gordana Bubanović; Matthias Linke; Ivan Sabol; Oliver Vugrek; Petar Ozretić; Luka Brčić; Sven Seiwerth; Željko Debeljak; Antonija Jakovčević; Zoran Janevski; Dinko Stančić-Rokotov; Andrea Vukić-Dugac; Marko Jakopović; Miroslav Samaržija; Ulrich Zechner; Jelena Knežević
Journal:  Transl Lung Cancer Res       Date:  2019-12

10.  Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.

Authors:  Abdurrahman Dolunay; Sefika Pinar Senol; Meryem Temiz-Resitoglu; Demet Sinem Guden; Ayse Nihal Sari; Seyhan Sahan-Firat; Bahar Tunctan
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.